Characterizing high- and low-grade glioma in treatment-naive patients, Verma et al. demonstrated higher 68Ga-PSMA-11 uptake and tumor-to-background ratio in high-grade glioma than in low-grade ones. The gene discussed is FOLH1; the disease is glioma.